Brensocatib significantly reduced the rate of pulmonary exacerbations and slowed lung function decline in patients with ...

The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Incorporated announced that positive results from the pivotal phase 3 ASPEN study of brensocatib in patients with non-cystic ...

Pope Francis’ doctor is sharing new details about the 88-year-old pontiff's final hours, including why Francis wasn’t ...

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

Pope Francis died of a cerebral stroke that put him into a coma, leading to heart failure, the Vatican has announced. The ...

Pope Francis was treated for double pneumonia, an infection in both lungs, before he died on Monday at the age of 88 .

"Brensocatib has the potential to transform the treatment landscape for bronchiectasis and we were pleased to receive the FDA acceptance of our NDA with priority review even earlier than ...

At 88 years old, Pope Francis died, the Vatican announced on April 21. His cause of death was a cerebral stroke which put him ...

Pope Francis' death certificate, released by the Vatican, said he died in his apartment at 7:35 a.m. from cerebral stroke, ...

Following the Vatican's announcement of Pope Francis’ death on April 21, doctors are speaking about the health conditions he ...